Skip to main content
CSL Ltd. logo

CSL Ltd. — Investor Relations & Filings

Ticker · CSL ISIN · AU000000CSL8 LEI · 529900ECSECK5ZDQTE14 ASX Manufacturing
Open in API
Filings indexed 2,555 across all filing types
Latest filing 2010-09-14 Transaction in Own Shar…
Country AU Australia
Listing ASX CSL

About CSL Ltd.

https://www.csl.com/

CSL is a global biotechnology company that researches, develops, manufactures, and markets a diverse portfolio of medicines. The company operates through distinct business units. CSL Behring provides plasma-derived and recombinant biotherapies for patients with rare and serious diseases, including bleeding disorders, immunodeficiencies, and neurological disorders. CSL Seqirus is a leading provider of vaccines, with a focus on influenza prevention and public health. CSL Vifor specializes in therapies for iron deficiency and nephrology, addressing the full spectrum of kidney disease. Collectively, CSL delivers lifesaving and life-enhancing treatments to a global patient population.

Recent filings

Filing Released Lang Actions
Daily share buy-back notice - Appendix 3E 2 pages ?Kb
Transaction in Own Shares Classification · 100% confidence The document is titled 'Appendix 3E Daily share buy-back notice' and contains detailed information about the company's on-market share buy-back activity, including number of shares bought back, prices paid, and compliance statements. It references ASX rules and is a formal notice related to share repurchase activity. The document length is 2677 characters, which is relatively short but contains substantive data about share buy-back transactions. This matches the description of a 'Transaction in Own Shares' filing, which reports the company's buy-back of its own shares. It is not an announcement of a report, nor a general regulatory filing, but a specific transaction report. Therefore, the correct classification is POS (Transaction in Own Shares).
2010-09-14 English
Daily share buy-back notice - Appendix 3E 2 pages ?Kb
Transaction in Own Shares Classification · 100% confidence The document is titled 'Appendix 3E Daily share buy-back notice' and contains detailed information about the company's share buy-back activity, including the number of shares bought back, total consideration paid, prices paid, and compliance statements. It references ASX rules and is a daily notice of share repurchase activity. The document length is 2915 characters, which is relatively short but contains substantive data about the buy-back. This matches the description of a 'Transaction in Own Shares' filing, which reports the company's buying back or selling its own shares. It is not an announcement of a report or a certification, but a direct report of share buy-back activity. Therefore, the correct classification is POS (Transaction in Own Shares).
2010-09-13 English
Annual Report to shareholders 124 pages ?Kb
Regulatory Filings
2010-09-09 English
Notice of Annual General Meeting/Proxy Form 13 pages ?Kb
Regulatory Filings
2010-09-09 English
Changes relating to buy-back - Appendix 3D 4 pages ?Kb
Regulatory Filings Classification · 95% confidence The document is titled 'Appendix 3D Changes relating to buy-back' and references ASX (Australian Securities Exchange) rules and compliance statements related to a share buy-back program. It details changes in buy-back proposals, broker appointment, maximum number of shares to be bought back, and compliance with Corporations Act requirements. The document is a formal announcement of changes to an existing buy-back program rather than a full financial report or detailed analysis. It is also relatively short (4465 characters) and structured as a regulatory form submission to ASX. This fits the category of a Regulatory Filing (RNS) as it is a compliance and disclosure document related to corporate actions but not a full report or financial statement. Therefore, the appropriate classification is Regulatory Filings (RNS).
2010-09-07 English
Appendix 3B 7 pages ?Kb
Capital/Financing Update Classification · 100% confidence The document is titled 'Appendix 3B New issue announcement' and contains detailed information about the issuance of new securities, including the class and number of securities issued, issue price, purpose, dates, and quotation application to the ASX (Australian Securities Exchange). It references specific ASX rules and the Corporations Act, indicating it is a regulatory filing related to capital raising and securities issuance. The document is not a financial report, earnings release, or management discussion but a formal announcement of new share issuance and application for quotation. This fits the definition of a Capital/Financing Update (CAP) filing, which covers updates on company fundraising and capital structure changes.
2010-09-07 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.